Table 2.
Outcomes measured in systemic antibiotic treatment as an adjunctive therapy in scaling and root planing.
Clinical and microbiological outcomes |
Caton et al. 2000 [10] |
Golub et al. 2001 [7] |
Novak et al. 2002 [11] |
Preshaw et al. 2004 [12] |
Preshaw et al. 2008 [18] |
Guerrero et al. 2005 [14] |
Reinhardt et al. 2007 [15] |
Needleman et al. 2007 [16] |
Griffiths et al. 2011 [17] |
---|---|---|---|---|---|---|---|---|---|
(1) CAL gain | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ |
(2) PD reduction | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ |
(3) % of BOP | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ||
(4) Adverse events | ∗ | ∗ | |||||||
(5) Gingival inflammation index | ∗ | ∗ | |||||||
(6) Plaque index | ∗ | ||||||||
(7) Metabolic activity in GCF | ∗ | ∗ | |||||||
(8) Proportion of spirochetes | ∗ | ||||||||
(9) Antibiotic sensitivity of microflora | ∗ |
CAL: clinical attachment level; PD: probing depth; BOP: bleeding on probing depth; metabolic activity in GCF gingival crevicular fluid.